Please assess the completion status of the following clinical trial:

Trial Title: Asimadoline for the Treatment of Post-Operative Ileus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females aged 18-80~* Must be scheduled to undergo a laparoscopic/hand-assisted laparoscopic segmental colectomy~* Must sign an ICF~* Females of childbearing potential must have a negative pregnancy test at screening~Exclusion Criteria:~* Subjects with evidence of a biochemical or structural abnormality of the GI tract or other co-morbid illness that may impact the ability to interpret the safety and efficacy data~* Pregnant or breastfeeding females~* Use of investigational drugs in previous 30 days~* Refusal to discontinue prohibited concomitant medications~* Chronic use of prescription narcotics over the previous 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Asimadoline 1.0 mg (Type: ACTIVE_COMPARATOR): Asimadoline 1.0 mg b.i.d.
- Asimadoline 3.0 mg (Type: ACTIVE_COMPARATOR): Asimadoline 3.0 mg b.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).